Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1995
11/28/1995US5470727 Chromosomal expression of non-bacterial genes in bacterial cells
11/28/1995US5470724 Boomerang DNA amplification
11/28/1995US5470722 Method for the amplification of unknown flanking DNA sequence
11/28/1995US5470721 Production of human somatomedin C
11/28/1995US5470720 HIV antibody assays comprising p24-gp41 chimeric antigens
11/28/1995US5470719 Nucleic acid code sequences
11/28/1995US5470718 Gene code polypeptides
11/28/1995US5470716 Method for diagnosing kawasaki syndrome
11/28/1995US5470712 Diagnosis of Lyme disease
11/28/1995US5470702 HIV-2 transmembrane glycoprotein homodimer (gp 80)
11/28/1995US5470573 Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174
11/28/1995US5470572 Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
11/28/1995US5470569 Genetic engineering
11/28/1995US5470560 Method for evaluating immunogenicity
11/28/1995US5470359 Sterile male corn plant
11/28/1995CA2150092A1 Transgenic animals lacking proteolipid protein and method of making such animals
11/28/1995CA1337671C Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
11/28/1995CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto
11/28/1995CA1337641C Recombinant dna product and method
11/28/1995CA1337640C Recombinant dna product and method
11/23/1995WO1995031729A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995WO1995031728A1 Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
11/23/1995WO1995031727A1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
11/23/1995WO1995031564A2 Method of introducing pathogen resistance in plants
11/23/1995WO1995031562A1 Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031559A2 Methods of inducing gene expression by ionizing radiation
11/23/1995WO1995031558A1 Process for producing hbv surface proteins
11/23/1995WO1995031555A1 Fusion glycoprotein from hcmv and hsv
11/23/1995WO1995031551A1 Novel enzymatic rna molecules
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031549A1 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
11/23/1995WO1995031548A1 Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
11/23/1995WO1995031547A1 Brazzein sweetener
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031542A1 Mutant human insulin receptor dna
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031540A1 Trimerising polypeptides, their manufacture and use
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031483A1 Improvements in or relating to peptide delivery
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031480A1 Heterodimer polypeptide immunogen carrier composition and method
11/23/1995WO1995031479A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995WO1995031478A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
11/23/1995WO1995031477A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995WO1995031476A1 Recombinant papilloma virus l1
11/23/1995WO1995031473A1 Collagen from cell cultures
11/23/1995WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031466A1 Method of detecting prions in a sample and transgenic animal used for same
11/23/1995WO1995031459A1 Morpholino-subunit combinatorial library and method
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995WO1995031216A1 Vaccine against mycobacterial infections
11/23/1995WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS)
11/23/1995WO1995031212A1 Human cd7 related compositions and methods of using the same
11/23/1995WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1)
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995031107A1 Immunotherapeutic strategies for the treatment of cancer
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft
11/23/1995WO1994013701A3 Delta-like gene expressed in neuroendocrine tumors
11/23/1995CA2490080A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995CA2190529A1 Fusion glycoprotein from hcmv and hsv
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190502A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995CA2190466A1 Monocyte chemotactic protein-4
11/23/1995CA2190375A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995CA2190353A1 Cloning of non-iga fc binding forms of the group b streptococcal beta antigens
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190264A1 Trimerising polypeptides, their manufacture and use
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995CA2190160A1 Method of detecting prions in a sample and transgenic animal used for same
11/23/1995CA2190120A1 Mutant human insulin receptor dna
11/23/1995CA2190101A1 Improvements in or relating to peptide delivery
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189421A1 Collagen from cell cultures
11/23/1995CA2188562A1 Method of introducing pathogen resistance in plants
11/23/1995CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995CA2186615A1 Novel enzymatic rna molecules
11/22/1995EP0683234A1 ANTIBODY AGAINST $g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
11/22/1995EP0683233A2 Process for producing recombinant human serum albumin
11/22/1995EP0683230A1 Vitreoscilla haemoglobin promoter/regulator controlled by the level of oxygen
11/22/1995EP0683229A2 Process for the preparation of recombinant aprotinin and recombinant aprotinin variants with natural N-terminal sequence
11/22/1995EP0683228A2 Novel expression system
11/22/1995EP0683227A1 Human retinoic acid receptor and genes encoding for it
11/22/1995EP0683226A1 Transgenic animals as a model for metabolic bone diseases
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0682951A1 Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies direced against them - application for the diagnosis
11/22/1995EP0682950A1 Mucosal administration of pneumococcal antigens
11/22/1995EP0682949A1 Virus inactivated antithrombin-III preparation free from pyrogen and thermally denatured protein
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
1 ... 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 ... 2916